Categories: AppsDNAHealthcareNews

Volta Labs, Inc. Launches Access Program to Support Academic Researchers Amid Budget Cuts

FacebookFacebookTwitterTwitterEmailEmailLinkedInLinkedInWhatsAppWhatsAppMessengerMessengerFlipboardFlipboardGmailGmailTelegramTelegramShareShare

BOSTON, April 28, 2025 /PRNewswire/ — Volta Labs, Inc. today announced the launch of the Volta Access Program, a new initiative aimed at increasing access to its Callisto™ Sample Prep System for academic research institutions in the U.S. facing tightening capital budgets. Selected applicants will be able to access Callisto for $4,950 per month over a 24-month term, with full service support and no consumables minimum — helping labs stay productive even as financial caution shapes decision-making across the academic community. The program, which runs through July 31, 2025, offers a flexible monthly payment structure to help researchers continue driving innovation in genomics without upfront equipment costs. Labs must apply to be considered for the program.

The Volta Access Program gives academic labs access to Callisto for $4,950 per month over a 24-month term.

“At a time when labs are being forced into essential spending only, we’re meeting researchers where they are — cautious, budget-conscious, but still determined to advance critical research for healthcare and national security,” said Udayan Umapathi, CEO of Volta Labs. “The need for advancements in research doesn’t stop because of tight budgets, and neither should access to the tools that drive discovery.”

The program addresses the challenges many institutions are facing, including NIH budget cuts, grant uncertainty, and widespread freezes on capital purchases and hiring, as labs prioritize conserving funds and delaying new projects unless absolutely necessary. Callisto is specifically designed for ease of use, requiring no skilled labor and minimal personnel to operate. By reducing reagent consumption during library preparation and minimizing costly sequencing reruns, Callisto drastically lowers operational expenses for genomics labs.

Program highlights:

  • Callisto access for $4,950/month over 24 months
  • Service contract included for ongoing support and seamless operations
  • No minimum consumables commitment, ensuring complete usage flexibility
  • At the end of the term, customers can either continue monthly payments or purchase the system at a significantly discounted price
  • Immediate access to the full available apps menu and all apps launched during the duration of the access program

Current apps menu includes:

  • High Molecular Weight DNA Extraction
  • DNA Extraction for Short Read Sequencing
  • DNA Library Prep for Illumina
  • PacBio SMRTBELL 3.0 Library Prep
  • Hybrid Capture for IDT XGen™, V2 Chemistry
  • Double-Sided Size Selection

*Submissions are limited to U.S.- based academic labs and must be received by July 30, 2025. Interested applicants, please reach out to sales@voltalabs.co for more information.*

About Volta Labs
Volta Labs is a genomics applications company that has developed a cutting-edge digital fluidics platform to maximize performance and scalability of sample preparation in genomics while providing unparalleled consistency. Volta is transforming the way biological research and analyses are performed, allowing scientists to focus on what they do best — pushing the boundaries of biology.

Media contact:
Abdul Mohammed
abdul@voltalabs.co 

View original content to download multimedia:https://www.prnewswire.com/news-releases/volta-labs-inc-launches-access-program-to-support-academic-researchers-amid-budget-cuts-302440003.html

SOURCE Volta Labs Inc.

Staff

Recent Posts

ZEISS Vision Care US Names Healthcare Industry Veteran Gary Rosenblum as President and Chief Executive Officer

Most Recently Serving as President for Oticon, a Division of Demant, Rosenblum Brings 30+ Years…

3 hours ago

TriSalus Life Sciences Announces Commencement of Exchange Offer and Consent Solicitation Relating to Series A Convertible Preferred Stock to Streamline Capital Structure

WESTMINSTER, Colo.--(BUSINESS WIRE)--TriSalus Life Sciences® Inc. (Nasdaq: TLSI), a company working to improve outcomes for…

6 hours ago

As Dangerous US Heat Wave Intensifies, AccuWeather Urges Public to Rely on Science-Backed RealFeel® Temperature for Accurate Danger Index

AccuWeather's RealFeel® Temperature is the only authentic formula-based metric—unlike 'Feels Like,' which lacks scientific credibility.Request…

6 hours ago

New Data Signals IVD Growth in a Shifting Market Amid Tariff Uncertainty

Kalorama Identifies Point-of-Care Testing Momentum and Strategic Blind Spots in Latest Diagnostic Trends Analysis ARLINGTON,…

6 hours ago

Medmovie Hx Heart App Launch Elevates Health Literacy and Empowers Shared Decision Making for Cardiovascular Care

Digital tool equips healthcare providers with trusted visual content to simplify complex heart information at…

6 hours ago

Premera Blue Cross Blue Shield of Alaska Announces Actions to Simplify Prior Authorization Process

Blue Cross and Blue Shield companies aim to improve the prior authorization process to make…

6 hours ago